BCA
EW icon

Bay Colony Advisors’s Edwards Lifesciences EW Stock Holding History

Bay Colony Advisors’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$652K Buy
7,208
+1,950
+37% +$163K 0.07% 220
2026
Q1 		$421K Sell
5,258
-9
-0.2% -$742 0.05% 297
2025
Q4 		$449K Buy
5,267
+9
+0.2% +$739 0.05% 299
2025
Q3 		$409K Buy
5,258
+3
+0.1% +$234 0.05% 325
2025
Q2 		$411K Sell
5,255
-100
-2% -$7.46K 0.06% 284
2025
Q1 		$380K Hold
5,355
– – 0.06% 288
2024
Q4 		$396K Buy
5,355
+15
+0.3% +$1.05K 0.06% 276
2024
Q3 		$352K Sell
5,340
-3
-0.1% -$218 0.05% 291
2024
Q2 		$494K Buy
5,343
+3
+0.1% +$266 0.08% 218
2024
Q1 		$510K Hold
5,340
– – 0.09% 207
2023
Q4 		$407K Sell
5,340
-967
-15% -$67.3K 0.08% 231
2023
Q3 		$437K Buy
+6,307
New +$507K 0.11% 184
2022
Q3 		– Sell
-2,335
Closed -$235K – 336
2022
Q2 		$235K Buy
+2,335
New +$242K 0.06% 287

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Bay Colony Advisors's EW Position: Q2 2026 in Review

Bay Colony Advisors increased its Edwards Lifesciences (EW) stake by 37% in Q2 2026, buying an estimated $163K and bringing the position to 7,208 shares worth $652K. The position accounts for 0.07% of the portfolio, ranked #220.

Bay Colony Advisors first reported a position in EW in Q2 2022 and has held it in 13 quarters since. 1,327 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Bay Colony Advisors held 7,208 shares of Edwards Lifesciences worth $652K as of Q2 2026.
  • Bay Colony Advisors bought 1,950 Edwards Lifesciences shares in Q2 2026, an estimated $163K.
  • Edwards Lifesciences made up 0.07% of Bay Colony Advisors's portfolio in Q2 2026, its #220 holding.
  • Bay Colony Advisors first reported a position in Edwards Lifesciences in Q2 2022 and has held it in 13 quarters since.
  • 1,327 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Bay Colony Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.